Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

LGBTQ+

- PMLiVE

Royalty Pharma raises Elan bid as deals keep coming

Values Elan at about $6.5bn

- PMLiVE

Pfizer pulls late-stage trial of cancer drug in NHL

Inotuzumab ozogamicin fails to show survival benefit in phase III

- PMLiVE

Actavis to buy Warner Chilcott in $8.5bn deal

Combined company will have annual revenues of about $11bn

- PMLiVE

UK pharmacists get social media guidance

Royal Pharmaceutical Society collects crowd-sourced tools and information on how to use Twitter, Facebook etc

Healthcare at Home and QED partner on orphan diseases

OrphanReach alliance will see companies provide product lifecycle services

- PMLiVE

Boehringer’s Wolfram Carius to step down

He will be replaced by Wolfgang Baiker on the board of managing directors

- PMLiVE

Chasing the cure for Parkinson’s disease

Research for this common neurodegenerative disease has made remarkable progress over the last decade, but current therapies can only reduce its symptoms

- PMLiVE

Is it a commitment issue?

How to manage your strategy in times of doubt

- PMLiVE

New vortioxetine studies reinforce efficacy in depression

Supports marketing applications from Takeda and Lundbeck

- PMLiVE

India puts cost controls on medicines

Drugs (Prices Control) Order 2013 reduces price of hundreds of drugs

Sanofi reception

Sanofi reconsiders closure plans in Toulouse after government pressure

Report says research site can remain open with minimal job losses

NHS to receive £260m for patient safety technology

Majority of hospital fund will be used for electronic prescribing

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links